Pierre Fabre Laboratories, a global health-care company from France, announced June 18 the opening of its new U.S. office located at 500 Plaza Drive in Secaucus. Pierre Fabre is the world’s second-largest dermo-cosmetics manufacturer and a global player in oncology, cell & gene therapy, rare disease and dermatology.
This strategic move marks a pivotal moment in the company’s growth strategy, underscoring its strong commitment to advancing its dermo-cosmetics and medical care in the U.S.
Building upon its success in oncology and dermatology in Europe and Asia, the company has recently expanded its medical care investments in the U.S. through the creation of a dedicated pharmaceutics unit, Pierre Fabre Pharmaceuticals (PFP).
“We have declared the United States a priority geography for the company,” said Eric Ducournau, CEO of Pierre Fabre Laboratories. The U.S. is not only the biggest market in the world for pharmaceuticals and cosmetics alike but also the most disruptive market for therapeutic innovation. For 15 years, we have built strategic partnerships with highly innovative U.S. biotechnology companies in the fields of oncology, rare diseases and medical dermatology.
“We are now determined to walk the next step forward, and the opening of our new office in Secaucus with plans to expand in the rare diseases and oncology business is a testimony to this dedication.”
“Today’s opening demonstrates the steadfast commitment of Pierre Fabre Laboratories to build a powerful presence for medical innovation and patient impact in the U.S.,” said CEO of PFP Adriana Herrera. “Leveraging our strength as a humanitarian foundation-owned company, PFP has been focused over the past 18 months on building U.S. medical care operations and to bring on board an experienced, agile and purpose-driven U.S. team focused on creating long-term value and hope for patients by delivering innovative therapies to people living with cancer who are in urgent need of effective, life-extending treatment options.”
With this new opening, Pierre Fabre Laboratories is positioning itself for even greater impact with American patients and health-care professionals in dermo-cosmetics and pharmaceuticals.
